Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kistler, J. P.
Right arrow Articles by Ojemann, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kistler, J. P.
Right arrow Articles by Ojemann, R. G.

Stroke, Vol 10, 26-29, Copyright © 1979 by American Heart Association


ARTICLES

Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report

JP Kistler, RS Lees, G Candia, NT Zervas, RM Crowell and RG Ojemann

Cerebral arteriospasm is a common complication of subarachnoid hemorrhage and is responsible for much of the brain damage which accompanies it. No pharmacologic agent has been found which regularly alleviates arteriospasm. We have evaluated the effect of continuous intravenous nitroglycerin infusion on the diameter of the basilar artery in dogs with cerebral vasospasm experimentally induced by subarachnoid blood injection. In 6 consecutive dogs, 10 minutes after beginning intravenous nitroglycerin at 100 microgram/min and at other times during 120 minutes of infusion, the diameter of the basilar artery had increased from 75 +/- 2% of control value to 114 +/- 2% of control value (p less than 0.001). In all 6 dogs, the basilar artery diameter during infusion was greater than the control value prior to creating subarachnoid hemorrhage. Intravenous nitroglycerin caused only a moderate (8%) decrease in blood pressure. Further investigation of the effects of nitroglycerin on cerebral vasospasm is warranted.


This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
D. L. Guettler and S.-X. Ma
Effects of Nitric Oxide and Noradrenergic Activation in the Posterior Hypothalamus on Arterial Pressure Tolerance to Nitroglycerin in Rats
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 98 - 106.
[Abstract] [PDF]


Home page
JAMAHome page
R. M. Pluta, A. Dejam, G. Grimes, M. T. Gladwin, and E. H. Oldfield
Nitrite Infusions to Prevent Delayed Cerebral Vasospasm in a Primate Model of Subarachnoid Hemorrhage
JAMA, March 23, 2005; 293(12): 1477 - 1484.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. A. Sehba, W. H. Ding, I. Chereshnev, J. B. Bederson, and J. P. Muizelaar
Effects of S-Nitrosoglutathione on Acute Vasoconstriction and Glutamate Release After Subarachnoid Hemorrhage • Editorial Comment
Stroke, September 1, 1999; 30(9): 1955 - 1961.
[Abstract] [Full Text] [PDF]